We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+7.34%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$6.59B
AUM Growth
+$680M
Cap. Flow
+$262M
Cap. Flow %
3.98%
Top 10 Hldgs %
67.98%
Holding
142
New
14
Increased
46
Reduced
57
Closed
13

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$47.5M
2
MSFT icon
Microsoft
MSFT
+$42.5M
3
TMO icon
Thermo Fisher Scientific
TMO
+$37.3M
4
ECL icon
Ecolab
ECL
+$36.9M
5
SBUX icon
Starbucks
SBUX
+$33.8M

Top Sells

Rank Stock Value
1
HDB icon
HDFC Bank
HDB
+$101M
2
PM icon
Philip Morris
PM
+$21.2M
3
META icon
Meta Platforms (Facebook)
META
+$11.4M
4
CELG
Celgene Corp
CELG
+$9.78M
5
MRK icon
Merck
MRK
+$8.94M

Sector Composition

Rank Sector Weight
1 Financials 26.2%
2 Healthcare 18.75%
3 Consumer Discretionary 17.75%
4 Communication Services 14.57%
5 Materials 7.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZVRA icon
101
Zevra Therapeutics
ZVRA
$559M
$1.53M 0.02%
23,856
+12,500
+110% +$823K
WBA
102
DELISTED
Walgreens Boots Alliance
WBA
$1.48M 0.02%
18,947
+3,103
+20% +$255K
AFAM
103
DELISTED
Almost Family Inc
AFAM
$1.48M 0.02%
+24,000
New +$1.31M
TJX icon
104
TJX Companies
TJX
$178B
$1.24M 0.02%
+34,200
New +$1.29M
OTEX icon
105
Open Text
OTEX
$6.2B
$1.2M 0.02%
+29,400
New +$970K
DCOY
106
Decoy Therapeutics
DCOY
$2.15M
– –
0
– –
PFNX
107
DELISTED
Pfenex Inc.
PFNX
$984K 0.01%
+245,500
New +$1.13M
JPM icon
108
JPMorgan Chase
JPM
$931B
$941K 0.01%
10,300
– –
T icon
109
AT&T
T
$167B
$913K 0.01%
+32,041
New +$944K
CVX icon
110
Chevron
CVX
$382B
$803K 0.01%
7,700
– –
VRTX icon
111
Vertex Pharmaceuticals
VRTX
$124B
$773K 0.01%
6,000
-818
-12% -$98.5K
FIS icon
112
Fidelity National Information Services
FIS
$23.7B
$686K 0.01%
8,030
– –
CCI icon
113
Crown Castle
CCI
$33.3B
$610K 0.01%
6,085
-8,215
-57% -$807K
TSS
114
DELISTED
Total System Services, Inc.
TSS
$600K 0.01%
10,300
-13,300
-56% -$761K
AZO icon
115
AutoZone
AZO
$51.1B
$477K 0.01%
837
– –
FSTX
116
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$340K 0.01%
+6,281
New +$291K
IONS icon
117
Ionis Pharmaceuticals
IONS
$9.1B
$282K ﹤0.01%
5,535
-467
-8% -$21.7K
RDUS
118
DELISTED
Radius Health, Inc.
RDUS
$280K ﹤0.01%
6,200
-1,197
-16% -$45.7K
BLUE
119
DELISTED
bluebird bio
BLUE
$221K ﹤0.01%
162
-28
-15% -$33.8K
BAP icon
120
Credicorp
BAP
$30.6B
$208K ﹤0.01%
1,161
– –
ESPR
121
DELISTED
Esperion Therapeutics
ESPR
$197K ﹤0.01%
4,247
-353
-8% -$13K
ACAD icon
122
Acadia Pharmaceuticals
ACAD
$4.44B
$194K ﹤0.01%
6,941
-564
-8% -$16.8K
LXRX icon
123
Lexicon Pharmaceuticals
LXRX
$1.03B
$178K ﹤0.01%
10,793
-884
-8% -$13.7K
SNDX icon
124
Syndax Pharmaceuticals
SNDX
$1.69B
$155K ﹤0.01%
11,100
-800
-7% -$9.14K
ICPT
125
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$147K ﹤0.01%
1,216
-107
-8% -$12.4K
2 3 4
5
6

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q2 2017 Portfolio in Review

As of Q2 2017, C WorldWide Group held 142 positions worth $6.59B, up 12% from $5.91B the previous quarter. Its ten largest holdings account for 68% of the portfolio.

C WorldWide Group deployed $262M of net new capital in Q2 2017, opening 14 new positions and adding to 46 existing holdings. Its largest new stake was Bristol-Myers Squibb: 267,012 shares worth $14.9M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was HDFC Bank, an estimated $101M trimmed.

  • C WorldWide Group's largest Q2 2017 buy was Bristol-Myers Squibb: 267,012 shares worth $14.9M.
  • C WorldWide Group added most to Visa in Q2 2017, an estimated $47.5M increase.
  • C WorldWide Group's biggest Q2 2017 reduction was HDFC Bank, cutting an estimated $101M.
  • C WorldWide Group fully exited Novadaq Technologies Inc. in Q2 2017, selling an estimated $3.86M.
  • C WorldWide Group's ten largest holdings make up 68% of its $6.59B portfolio in Q2 2017.
  • C WorldWide Group opened 14 new positions and closed 13 in Q2 2017.
  • C WorldWide Group's portfolio value rose 12% quarter-over-quarter to $6.59B.

Based on C WorldWide Group's 13F filing for Q2 2017, filed 2 Aug 2017.